| |
|
|
 |
- Address:
- 300 George Street
New Haven, CT 06511
- Phone:
- (203) 624-7000
- Website:
- http://www.achillion.com
-
- Company Information:
-
Achillion Pharmaceuticals Inc., is located at New Haven, CT and is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease.
The Company’s proven discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease — HIV, hepatitis and resistant bacterial infections.
Achillion’s drug development pipeline is led by elvucitabine (Beta-L-Fd4C or ACH-126,443), which is currently in late-stage Phase 2 clinical trials for the treatment of patients infected with HIV.
We diversify our portfolio via highly integrated internal drug discovery programs in diseases representing significant markets, as well as through opportunistic in-licensing. We leverage our internal drug development expertise to speed the development of clinical candidates through Phase 2 studies and into registrational trials, thereby adding value to product candidates via our intrinsic capabilities. Achillion expects to earn revenue by selling its infectious disease drug products worldwide, either through its own marketing and sales operations, or by working in partnership with a pharmaceutical partner.
|
 |
|
|
